Organotin meclofenamic complexes: Synthesis, crystal structures and antiproliferative activity of the first complexes of meclofenamic acid - Novel anti-tuberculosis agents |
| |
Authors: | Dimitra Kovala-Demertzi Vaso Dokorou Alexandra Primikiri Cristian Silvestru Mavroudis A Demertzis |
| |
Institution: | a Section of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece b Faculty of Chemistry and Chemical Engineering, “Babes-Bolyai” University, RO-400028 Cluj-Napoca, Romania c Dipartimento di Chimica Inorganica, Metallorganica e Analitica, Universita di Padova, Via Loredan 4, I-35131 Padova, Italy |
| |
Abstract: | The complexes Me2(Meclo)SnOSn(Meclo)Me2]2 (2) and Ph3Sn(Meclo)] (3) where HMeclo is meclofenamic acid, N-(2,6-dichloro-m-tolylanthranilic acid)], have been prepared and structurally characterized by means of vibrational, 1H and 13C NMR spectroscopies. The crystal structure of complexes (2) and (3) have been determined by X-ray crystallography. Three distannoxane rings are present to the dimeric tetraorganodistannoxane of planar ladder arrangement of (2). The structure is centro symmetric and features a central rhombus Sn2O2 unit two additional tin atoms linked at the oxygen atoms. Five- and six-coordinated tin centers are present in the dimer distannoxane. X-ray analysis of (3) revealed a penta-coordinated structure containing Ph3Sn coordinated to the chelated carboxylato group. The polar imino hydrogen atom participates in intra-molecular hydrogen bonds. Complexes (2) and (3) are self-assembled via π → π, C-H-π, stacking interactions and intra-molecular hydrogen bonds. Meclofenamic acid and Ph3Sn(Meclo)] have been evaluated for antiproliferative activity in vitro against three human cancer cell lines: MCF-7 (human breast cancer cell line), T24 (bladder cancer cell line), A-549 (non-small cell lung carcinoma) and a mouse L-929 (a fibroblast-like cell line cloned from strain L). The Ph3Sn(Meclo)] complex exhibited high cytotoxic activity against all the cancer cell lines. Meclofenamic and Ph3Sn(Meclo)] were tested for anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv. The Ph3Sn(Meclo)] complex was found to be a promising anti-mycobacterial lead compound, displaying high activity against M. tuberculosis H37Rv. |
| |
Keywords: | Meclofenamic acid Ladder tetraorganodistannoxane Triphenyltin complex Crystal structures Spectroscopic studies Antiproliferative activity Novel anti-tuberculosis agents |
本文献已被 ScienceDirect 等数据库收录! |
|